Get the Stockscreener App
0.7588
10.92%
0.0747
Pre-market:
.80
0.0412
+5.43%
Allurion Technologies Inc stock is traded at $0.7588, with a volume of 502.79K.
It is up +10.92% in the last 24 hours and down -35.69% over the past month.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
See More
Previous Close:
$0.6841
Open:
$0.7
24h Volume:
502.79K
Relative Volume:
0.20
Market Cap:
$9.32M
Revenue:
$17.21M
Net Income/Loss:
$-23.45M
P/E Ratio:
-0.131
EPS:
-5.7938
Net Cash Flow:
$-36.90M
1W Performance:
-38.31%
1M Performance:
-35.69%
6M Performance:
-64.29%
1Y Performance:
-70.82%
1-Day Range:
$0.6926
$0.8207
1-Week Range:
$0.6524
$1.33
52-Week Range:
$0.6524
$4.18
Allurion Technologies Inc Stock (ALUR) Company Profile
Name
Allurion Technologies Inc
Sector
Industry
Phone
508-647-4000
Address
11 HURON DR STE 200, NATICK
Compare ALUR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALUR
Allurion Technologies Inc
|
0.7588 | 8.40M | 17.21M | -23.45M | -36.90M | -5.7938 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Allurion Technologies Inc Stock (ALUR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-24 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Oct-02-24 | Initiated | TD Cowen | Buy |
| Sep-06-24 | Initiated | ROTH MKM | Buy |
| Feb-09-24 | Initiated | Jefferies | Buy |
Allurion Technologies Inc Stock (ALUR) Latest News
GN Store Nord (OTCMKTS:GNNDY) and Allurion Technologies (NYSE:ALUR) Financial Survey - Defense World
CPUHCompute Health Acquisition Corp. Warrant Holders Hold Special Meeting - ADVFN Ltd
8 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session - Benzinga
RTW funds report 39.4% Allurion (ALUR) ownership in 13D amendment - Stock Titan
Allurion Technologies Appeals NYSE Delisting, Plans Compliance Strategy - TipRanks
NYSE initiates delisting proceedings against Allurion - Investing.com
Allurion intends to appeal NYSE notice of delisting, execute plan to regain compliance, and expects to continue trading on NYSE - marketscreener.com
ALLURION TECHNOLOGIES announced that the company plans to formally appeal the delisting notice issued by the New York Stock Exchange. - Bitget
Allurion Technologies Received Notice of Delisting - TradingView
NYSE moves to delist Allurion (NYSE: ALUR) as company plans appeal - Stock Titan
Nyse to commence delisting proceedings against Allurion Technologies, Inc. - marketscreener.com
Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE - Business Wire
Intercontinental Exchange : NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR) - marketscreener.com
NYSE To Commence Delisting Proceedings Against Allurion Technologies, Inc. - TradingView
NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR) - FinancialContent
Allurion Technologies (NYSE:ALUR) & CeriBell (NASDAQ:CBLL) Head-To-Head Survey - Defense World
ALUR Should I Buy - Intellectia AI
Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year? - Yahoo Finance
What's going on with Allurion stock on Wednesday? - MSN
FDA approves Allurion’s gastric balloon system - bioworld.com
Contrasting Allurion Technologies (NYSE:ALUR) and Metastat (OTCMKTS:MTST) - Defense World
What's Going On With Allurion Stock On Wednesday? - Benzinga
Allurion Technologies amends warrant terms and raises $3 million through inducement offer - Investing.com Nigeria
Allurion Technologies Amends Warrants to Bolster Liquidity - TipRanks
Allurion Lowers Warrant Exercise Price to $1.15, Raises ~$3M and Issues 5.32M New Warrants - TradingView
Allurion Technologies (ALUR) secures $3M via warrant repricing and new warrants - Stock Titan
Why Did Allurion Stock Surge Over 50% Today? - Stocktwits
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session - Benzinga
Nasdaq Gains Over 1%; Keurig Dr Pepper Earnings Top Views - Benzinga
Chardan Capital Upgrades Allurion Technologies (ALUR) - Nasdaq
Strategic Acquisition Amplifies Allurion’s Market Presence - StocksToTrade
Dow Gains Over 100 Points; Home Depot Posts Upbeat Earnings - Benzinga
Allurion Technologies upgraded to Buy from Neutral at Chardan - TipRanks
Allurion Technologies stock rating upgraded on FDA approval By Investing.com - Investing.com India
Allurion stock balloons as FDA signs off on weight loss device - Fierce Biotech
ALUR Sees Market Volatility Amidst Strategic Moves and Market Challenges - timothysykes.com
Allurion Technologies stock rating upgraded on FDA approval - Investing.com UK
Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds - Business Wire
Chardan Upgrades Allurion Technologies to Buy From Neutral, $3 Price Target - marketscreener.com
Earnings Recap: Is KOPN in a bullish channelJuly 2025 Market Mood & Accurate Buy Signal Alerts - baoquankhu1.vn
FDA approves Allurion gastric balloon for obesity treatment - Investing.com Australia
FDA Approves Swallowable Balloon for Weight Loss. How Does It Compare to GLP-1 Drugs? - TODAY.com
Dow Tumbles Over 700 Points; Dominion Energy Posts Upbeat Earnings - Benzinga
Allurion Wins FDA Nod for Alternative to GLP-1s - Medical Device and Diagnostic industry
12 Consumer Discretionary Stocks Moving In Monday's Intraday Session - Benzinga
Allurion Technologies Says Gastric Balloon System to Treat Obesity Premarket Approval Application Approved by FDA - marketscreener.com
ALUR | Allurion Technologies, Inc. FinancialsIncome Statement - Quiver Quantitative
Allurion gets FDA nod for weight loss balloon - MassDevice
Allurion Technologies Wins FDA's PMA Approval For Allurion Gastric Balloon System, Stock Soars - Nasdaq
Allurion Gets FDA Approval for Gastric Balloon System with Smart Capsule - Medical Product Outsourcing
Allurion’s Strategic Partnership to Boost Weight Loss Solutions - StocksToTrade
Allurion Technologies Inc Stock (ALUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):